Intervention | WHO recommendationsa | Inclusion in national guidelinesb | Coverage (%)c; median (range) |
---|---|---|---|
HIV | |||
 Prevention | ART prophylaxis from 14 weeks for PMTCT | Yes | No data |
 Screening | HIV testing at first ANC visit | Yes | 37.9% (14.7–52.4%) |
 Treatment | ART for mother starting immediately if CD4 count ≤ 350 cells/mm3 for mother’s own health (treatment of HIV and PMTCT) | Sometimes | No data |
Malaria | |||
 Prevention | IPTp at each ANC visit from 2nd trimester to delivery, doses ≥ 1 month apart, preferably DOT | Sometimes | 6.6% (0.1–40.9%)d |
 | Receive one LLIN through ANC visits | Sometimese | 39.7% (16.0–75.4%)f |
 Screening | No guidelines | N/A | N/A |
 Treatment | ‘Effective case management’ – presumptive treatment of symptoms/fever as per national guidelines | Rarely | No data |
TB | |||
 Prevention | TB infection control in PMTCT settings | No | No data |
 Screening | TB signs and/or symptoms should be evaluated for active TB HIV positive pregnant women should be screened for TB during HIV post-test counselling | Rarely Rarely | No data No data |
 Treatment | All first-line TB drugs (except streptomycin) | No | No data |